We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Articles

Results 1 to 5 of 24
Most popular |Most recent


Federal Circuit Corrects USPTO on Reasonable Efforts When Calculating Patent Term Adjustment

USA - January 25 2019 The Federal Circuit ruled on January 23, 2019, that the United States Patent and Trademark Office (“PTO”) erred in reducing the term of a patent owned...

Rachel A. Rice.

Patent Eligibility in the Life Sciences: Supreme Court Declines Review of Ariosa Diagnostics v. Sequenom

USA - June 30 2016 On June 27, 2016, the U.S. Supreme Court denied certiorari in Ariosa Diagnostics, Inc. v. Sequenom, Inc., thereby letting stand the Federal Circuit's...

Karen G Potter.

USPTO Issues New Subject Matter Eligibility Examples for Life Sciences

USA - May 12 2016 The United States Patent and Trademark Office (USPTO) recently provided updated guidance regarding the patent eligibility of subject matter related...

Amanda T. White, Karen G Potter.

No more isolated DNA patents, the Supreme Court rules

USA - June 13 2013 In a unanimous decision, the U.S. Supreme Court today ruled that naturally occurring, isolated human gene sequences are a product of nature, and thus...

Mary Prendergast.

After Myriad oral argument, Supreme Court set to decide patentability of isolated human DNA molecules

USA - April 15 2013 Today, the Supreme Court of the United States heard oral argument in Association for Molecular Pathology v. Myriad Genetics, Inc. (No. 12-398) to...

Matthew I. Kreeger, Marc A. Hearron.